Additionally, the GSEA analysis further confirmed significant enrichment of these DEGs in pathways such as Interferon gamma response, inflammatory response, epithelial mesenchymal transition, complement, and allograft rejection (Figures 1E, F), providing further insights into the molecular mechanisms underlying DKD. This evidence concerns the gene IFNG and diabetic kidney disease.